Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avant BrandsTSX:AVNT -4.62%31 3-1 Month Momentum % is -5.17% as of Aug. 16, 2026. GuruFocus rates TSX:AVNT with a GF Score™ of 31/100 and a GF Value™ of C$0.95 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,026 Drug Manufacturers companies, Avant Brands ranks better than 51.66% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-16), Avant Brands's 3-1 Month Momentum % is -5.17%.
The industry rank for Avant Brands's 3-1 Month Momentum % or its related term are showing as below:
TSX:AVNT's 3-1 Month Momentum % is ranked better than 51.66% of 1026
companies
in the Drug Manufacturers industry
Industry Median: -5.74
vs TSX:AVNT: -5.17
Avant Brands (TSX:AVNT) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Avant Brands 3-1 Month Momentum % Related Terms
TSX:AVNT vs ZTS: 3-1 Month Momentum % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avant Brands 3-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Avant Brands's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Avant Brands's 3-1 Month Momentum % falls into.
Avant Brands (TSX:AVNT) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avant Brands (TSX:AVNT) has a 3-1 Month Momentum % of -5.17% as of Aug. 16, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Avant Brands and its competitors. According to the industry distribution chart, Avant Brands ranks #496 out of 1026 companies in the Drug Manufacturers industry, placing it in the top 48.3%.
Is Avant Brands' 3-1 Month Momentum % too high?
Avant Brands' current 3-1 Month Momentum % is -5.17%. Based on the distribution chart, Avant Brands ranks #496 out of 1026 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Avant Brands has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Avant Brands' 3-1 Month Momentum % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Avant Brands ranks #496 out of 1026 companies for 3-1 Month Momentum %. This puts Avant Brands in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
A good 3-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Avant Brands and its competitors. Avant Brands's current 3-1 Month Momentum % is -5.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avant Brands stock overvalued right now?
Based on GuruFocus' analysis, Avant Brands (TSX:AVNT) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.95, compared to a current price of C$0.62 — trading 34.7% below its estimated fair value. The current 3-1 Month Momentum % is -5.17%. Avant Brands' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Avant Brands (TSX:AVNT), the current 3-1 Month Momentum % is -5.17% as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avant Brands (TSX:AVNT) Overvalued in 2026?
Based on GuruFocus' analysis, Avant Brands stock appears to be undervalued.
The current stock price of C$0.62 is trading 34.7% below its estimated GF Value™ of C$0.95.
GuruFocus considers Avant Brands to be Possible Value Trap.
Key valuation signals for TSX:AVNT:
3-1 Month Momentum %: -5.17%
GF Value™: C$0.95 vs. price of C$0.62 (34.7% below fair value)
No single metric tells the full story. See the TSX:AVNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avant Brands Inc operating in the cannabis industry, engages in the cultivation, production, marketing, and sale of cannabis products. Its product portfolio mainly consists of dried cannabis flower and related cannabis products, with the company managing the entire value chain from cultivation and harvesting to processing, packaging, and distribution, generating revenue upon delivery of products to customers. It operates in Canada.
31GF Score
Get the complete analysis for TSX:AVNT
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:AVNT has been successfully added to your 
